[go: up one dir, main page]

GB0804686D0 - Humanized antibody - Google Patents

Humanized antibody

Info

Publication number
GB0804686D0
GB0804686D0 GB0804686A GB0804686A GB0804686D0 GB 0804686 D0 GB0804686 D0 GB 0804686D0 GB 0804686 A GB0804686 A GB 0804686A GB 0804686 A GB0804686 A GB 0804686A GB 0804686 D0 GB0804686 D0 GB 0804686D0
Authority
GB
United Kingdom
Prior art keywords
humanized antibody
humanized
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0804686A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest AG
Original Assignee
Biotest AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest AG filed Critical Biotest AG
Priority to GB0804686A priority Critical patent/GB0804686D0/en
Publication of GB0804686D0 publication Critical patent/GB0804686D0/en
Priority to EP09727585.3A priority patent/EP2265643B1/en
Priority to AU2009231325A priority patent/AU2009231325B2/en
Priority to SG2013032545A priority patent/SG190598A1/en
Priority to CA2718184A priority patent/CA2718184A1/en
Priority to JP2010550181A priority patent/JP5597553B2/en
Priority to KR1020107022910A priority patent/KR20100135257A/en
Priority to NZ602521A priority patent/NZ602521A/en
Priority to BRPI0909048A priority patent/BRPI0909048A2/en
Priority to CN2009801173170A priority patent/CN102027017A/en
Priority to MX2010010028A priority patent/MX2010010028A/en
Priority to RU2010141826/10A priority patent/RU2539110C2/en
Priority to PCT/EP2009/052809 priority patent/WO2009121690A1/en
Priority to IL207891A priority patent/IL207891A0/en
Priority to US12/880,837 priority patent/US9334325B2/en
Priority to ZA2010/07215A priority patent/ZA201007215B/en
Priority to CR11724A priority patent/CR11724A/en
Priority to CO10127114A priority patent/CO6311007A2/en
Ceased legal-status Critical Current

Links

GB0804686A 2008-03-13 2008-03-13 Humanized antibody Ceased GB0804686D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0804686A GB0804686D0 (en) 2008-03-13 2008-03-13 Humanized antibody
PCT/EP2009/052809 WO2009121690A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
BRPI0909048A BRPI0909048A2 (en) 2008-03-13 2009-03-10 pharmaceutical composition and method of treating an autoimmune disease
MX2010010028A MX2010010028A (en) 2008-03-13 2009-03-10 Agent for treating disease.
SG2013032545A SG190598A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
CA2718184A CA2718184A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
JP2010550181A JP5597553B2 (en) 2008-03-13 2009-03-10 Disease treatment agent
KR1020107022910A KR20100135257A (en) 2008-03-13 2009-03-10 Disease Remedy
NZ602521A NZ602521A (en) 2008-03-13 2009-03-10 Agent for treating disease
EP09727585.3A EP2265643B1 (en) 2008-03-13 2009-03-10 Dosing regimen for treating psoriasis and rheumatoid arthritis
CN2009801173170A CN102027017A (en) 2008-03-13 2009-03-10 Agent for treating disease
AU2009231325A AU2009231325B2 (en) 2008-03-13 2009-03-10 Agent for treating disease
RU2010141826/10A RU2539110C2 (en) 2008-03-13 2009-03-10 Method of treating autoimmune disease (versions)
IL207891A IL207891A0 (en) 2008-03-13 2010-08-31 Agent for treating disease
US12/880,837 US9334325B2 (en) 2008-03-13 2010-09-13 Method for treating psoriasis
ZA2010/07215A ZA201007215B (en) 2008-03-13 2010-10-08 Agent for treating disease
CR11724A CR11724A (en) 2008-03-13 2010-10-11 AGENT TO TREAT DISEASES
CO10127114A CO6311007A2 (en) 2008-03-13 2010-10-13 PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +, EFFECTIVE AT LOW DOSE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0804686A GB0804686D0 (en) 2008-03-13 2008-03-13 Humanized antibody

Publications (1)

Publication Number Publication Date
GB0804686D0 true GB0804686D0 (en) 2008-04-16

Family

ID=39328067

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0804686A Ceased GB0804686D0 (en) 2008-03-13 2008-03-13 Humanized antibody

Country Status (1)

Country Link
GB (1) GB0804686D0 (en)

Similar Documents

Publication Publication Date Title
ZA201005348B (en) Humanized anti-c5ar antibodies
SG10201601279SA (en) Monoclonal Antibody STRO-4
EP2331579A4 (en) Monoclonal antibodies
IL204835A0 (en) Humanized antibody
EP2241578A4 (en) Anti-cldn6 antibody
AP3371A (en) Anti-IGF antibodies
EP2349331A4 (en) Humanized anti-il-6 antibodies
ZA201102119B (en) Improved antibody libraies
IL217919A0 (en) Humanized anti-cdcp1 antibodies
GB0821100D0 (en) Antibodies
HK1168871A1 (en) Monoclonal antibodies
IL207581A0 (en) Anti-tyrp1 antibodies
EP2274332A4 (en) Anti-tnf antibody
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
ZA201004770B (en) Improved humanized anti-human x9-integrin antibody
GB0911770D0 (en) Antibody
GB0804684D0 (en) Humanized antibody
GB0804686D0 (en) Humanized antibody
GB0804687D0 (en) Humanized antibody
GB0706964D0 (en) Humanized antibody
GB0706963D0 (en) Humanized antibody
GB0706965D0 (en) Humanized antibody
TWI348915B (en) Anti-vegf monoclonal antibody
GB0817621D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)